Refine by
Brain Imaging Articles & Analysis
27 news found
In addition to depression behavior testing services, Ace Therapeutics also provides drug safety and efficacy studies, new antidepressant development, biomarker-based diagnostic development, and brain imaging diagnostic development, all to facilitate the research on depression, deepen understanding, and ultimately contribute to more effective treatments and ...
Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. ...
Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...
Sydney, Australia - November 23, 2022 - Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that Imperial College London has released additional data related to the F-18 Pivalate (RAD 101) Phase 2a imaging trial in patients with brain metastases. ...
Importantly, patients receiving Lomecel-B were not reported to develop a serious side-effect called amyloid-related imaging abnormalities (ARIA) as assessed by magnetic resonance imaging (MRI). ...
VERITON-CT64 is designed for both, total body and organ-focused, hybrid imaging with shorter scan times, at lower injected activity when compared to current analog dual-detector technology. VERITON-CT64 SPECT/CT digital technology plus unique design enables routine hybrid 3D imaging for cardiac, brain, lung indications, and for the first time, ...
Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it is expanding its strategic supplier partnership with leading gradient index (GRIN) lens manufacturer GRINTECH GmbH to be the sole exclusive seller of GRIN lenses for neuroscience research applications. ...
The posters highlight Qynapse’s latest results with QyScore®, its commercially-available automated brain image analysis platform, demonstrating the reproducibility of its results and its value to inform the MS diagnostic standard. ...
ByQynapse
Chris Kent, CEO of Reveal Surgical, explained that the company uses Raman spectroscopy (which is an optical, non-invasive imaging technique) to “fingerprint” different types of tumors, allowing doctors to fingerprint a tissue sample and compare it to those on record via Reveal’s software. ...
Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF). ...
Swoop® was designed to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. In as little as 30 seconds after a Swoop scan, advanced artificial intelligence applications analyze and return annotated, segmented ...
Zhou Renhai, CEO of Deep01, said that in the field of AI medical care, Taiwan can make world-class products, and Deep01 is the best example. In the vertical field of brain CT imaging, Deep01 has achieved global leadership. The AI functions of Deep01 are more complete than those of overseas competitors, and the AI computing speed is nearly 10 times faster. In ...
Hyperfine’s Swoop® Portable MR Imaging SystemTM is designed to address the limitations of current imaging technologies and make MRI for brain imaging accessible anytime, anywhere, to any patient. ...
Combining engineering and medicine can lead to world-leading tools like the Raman spectroscopy, which can help to distinguish cancer cells from healthy cells; for example, in brain tumour surgery.ISTOCKPHOTO / GETTY IMAGES One of the biggest challenges in brain tumour surgery is making sure that all cancer cells are removed. ...
A PET scan is the traditional method to determine build-up of amyloid plaques in the brain among people who do not show symptoms of Alzheimer’s disease. ...
2021 Optina, an innovative diagnostics company leading the field of Retinal Imaging, Brain Health and Systemic Diseases Diagnostics, announced today the closing of an CA$24.8 million Series A round of funding. ...
Its international outlook is one of its most important pillars and the research focus is centered on immunology, cancer research, imaging, brain research and cardiovascular diseases. www.meduniwien.ac.at/web/en Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions ...
In Japan, clinical MRI scanners are available for the diagnosis and evaluation of dementia. Brain imaging by MRI is available for patients with dementia and the prodromal stages using standard health insurance. ...
This process may take years, and eventually requires invasive and costly tests like nuclear brain imaging such as a PET (positron-emission tomography) scan. But isn’t there a better way? That’s why the experts in imaging, engineering and artificial intelligence at Optina Diagnostics have been working for 6 years to find new ...
With full control over transmit profiles, researchers now have the power and freedom to develop and explore new imaging methods in a quick, iterative fashion—going beyond existing imaging modes. ...